Definitive Contract 75N92019C00002
Award Date 11/19/18
Potential Completion Date 11/18/21
Potential Value $725K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Houston, TX 77057, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- <p>This is a $199,969 Small Business Innovation Research (SBIR) Program Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Accelerated Medical Diagnostics, Inc. The contract is for "OTHER FUNCTIONS - R & D BIOMEDICAL (BASIC RESEARCH)" and has a firm fixed price pricing type with a completion date of September 30, 2016. As an SBIR Phase I award, this contract supports early-stage research and development activities.</p>
- The National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), awarded a $26,857 firm-fixed-price purchase order contract to Advanced Cell Diagnostics, Inc. (ACD) for the procurement of RNAscope In-House Assay or equivalent technology. This contract was awarded on July 21, 2025, with a completion date of September 25, 2025. ACD is a for-profit molecular diagnostics company specializing in advanced RNA detection technologies, including the RNAscope platform....
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services (HHS). The contract, valued at $249,723.00, was awarded to Detroit R&D, Inc., a minority-owned, economically disadvantaged, woman-owned small business located in Bloomfield Hills, Michigan. The contract is for research and development of a "Multiplex Label-Free Nanowell Technology...
- This is a $97,680 firm fixed price contract awarded by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services. The contract was set aside for small businesses and awarded to Mediomics LLC, a woman-owned small business. The contract is for the development of APTAMER-BASED PINCERS FOR CARDIOVASCULAR BIOMARKERS, which aligns with the National Heart Lung and Blood Institute's mission to support research on heart, lung, and blood...
- This federal contract awards $34,976.00 to Advanced Cell Diagnostics, Inc. (ACD), a for-profit manufacturer of molecular diagnostics, to provide the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases with various RNAscope kits and reagents. The contract is a firm-fixed-price purchase order with no set-aside designation. ACD, a subsidiary of Bio-Techne Corporation, has a strong track record of providing these types of...
- This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Advanced Cell Diagnostics, Inc. (ACD) for the delivery of reagent kits. The contract has a ceiling value of $5,042.00 and an ultimate completion date of December 21, 2015. ACD is a molecular diagnostics company specializing in RNA detection technologies, and its proprietary RNAscope technology has been utilized in...
- This is a $1,994,911.00 firm fixed price contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Earlydiagnostics Inc., doing business as Earlydx. The contract was awarded under the NCI SBIR Transition to Phase II Solicitation for fiscal year 2023 and has a total small business set-aside designation. Earlydx, a for-profit organization, will provide research and development services to support the development of a cloud-based...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm-fixed-price purchase order to Advanced Cell Diagnostics, Inc. (ACD) on March 19, 2024. The $13,804.00 contract is for the delivery of ACD's RNAscope assay biological products, including kits, reagents, and probes, with a completion date of June 30, 2024. ACD is a for-profit manufacturer of diagnostic tools for personalized medicine applications and has...
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $13,507.60 firm fixed price purchase order to Advanced Cell Diagnostics, Inc. for advanced cell diagnostics services. Advanced Cell Diagnostics, Inc. will perform as the prime contractor, with its parent company listed as Bio-Techne Corporation. The contract period of performance is from November 13, 2023 through January 5, 2024. It is presumed Advanced Cell Diagnostics, Inc. will provide their...
- This is a $16,100.00 firm fixed price purchase order awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency, to TRU Diagnostics Inc. The contract is to support research conducted by the Epidemiology and Community Health Branch (ECHB) and the Laboratory of Genomic Instability and Cardiopulmonary Outcomes (LOGICO) within the NHLBI's Division of Intramural Research. The contract provides third-party laboratory services and has an ultimate completion date of September...